Formula & Concentration
Novoeight®, Antihemophilic Factor (Recombinant) For Intravenous Injection. Lyophilized Powder for Solution Initial
Novoeight is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
Novoeight® is not indicated for the treatment of von Willebrand disease.
Shelf Life and Storage
Refrigerated up to thirty (30) months – Room temperature up to twelve (12) months / Store Novoeight under refrigeration at a temperature of 36°F-46°F (2°C – 8°C). Novoeight may also be stored at room temperature not to exceed 86°F (30°C).